Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

The companies Biohaven, MoonLake Immunotherapeutics, and AIRNA bagged the biggest biotech funding rounds overall in April ...

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions. Please check event websites for further ...

Hepatitis B is a serious liver infection that is caused by the hepatitis B virus (HBV). Around 254 million people live with hepatitis B, and 6000 people are newly infected with viral hepatitis each ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.